Other languages BRAIN Biotech AG

Equities

BNN

DE0005203947

Market Closed - Xetra Other stock markets 11:36:03 2024-05-31 am EDT			5-day change	1st Jan Change
2.8 ^EUR	-1.75%		+1.45%	-23.50%

May. 28	BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
Apr. 16	Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes	May. 29
BRAIN Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 28
BRAIN Biotech : receives major milestone payment and stays on-track to achieve year end targets	May. 28
BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets	May. 28
AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	May. 14
Brain Biotech Plans Merger by Absorption of AnalytiCon Discovery	Apr. 16
BRAIN Biotech AG takes next step to optimize group structure	Apr. 16
Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams	Mar. 14
Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG	Mar. 12
Collaboration between BRAIN Biotech and AMSilk, Protein engineering successfully improves structural proteins for performance materials	Mar. 06
BRAIN Biotech : Biocatalysts Ltd expands its Manufacturing Capabilities with Large-Scale Freeze Drying	Mar. 05
Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials	Mar. 05
BRAIN Biotech AG and AMSilk GmbH Announce the Successful Completion of the First Phase of A Development Collaboration	Mar. 05
BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives	Feb. 29
BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights	Feb. 29
BRAIN Biotech AG Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 28
3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24	Feb. 28
BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2023	Jan. 17
Annual Report 2022/23: BRAIN Biotech AG successfully executes growth strategy	Jan. 17
AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Jan. 10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages BRAIN Biotech AG

Equities

BNN

DE0005203947

Other languages

Filters